- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 949
Innovusion gets $30m funding infusion
The lidar technology startup has secured funding in a series A round co-led by Nio's corporate venturing arm and Fidelity's Eight Roads Ventures and F-Prime Capital units.
Oct 30, 2018Rakuten to exit as MakeLeaps jumps to Ricoh
Rakuten has scored an exit from digital invoicing platform MakeLeaps after Ricoh agreed to buy the company for a reported eight-figure amount.
Oct 29, 2018Wukongbao claims series B funding
Guohua Life Insurance and 58 Group supplied series B funding for online insurance platform Wukongbao, adding to $15.3m in pre-series A funding in 2016.
Oct 29, 2018QinBaoBao enters series C stage
TAL Education joined conglomerate Fosun and VC firm Shunwei Capital in a round for parenting app developer QinBaoBao sized in the eight-digit dollar range.
Oct 29, 2018News round up 29 October 2018
A round up of all the latest news on www.globalcorporateventuring.com for our subscribers.
Oct 29, 2018Epic reaches next level with $1.25bn
Axiomatic was among the new investors in Epic Games, developer of the hugely popular Fortnite, which is now valued at almost $15bn.
Oct 29, 2018Tado fires up $50m round
Amazon, Eon and Čez Group have backed a $50m funding round for smart thermostat manufacturer Tado that nearly doubled its equity to $102m.
Oct 29, 2018Galecto collects $90m in series C
Bristol Myers-Squibb, Merck Group and Novo all took part in a $90m series C round for Galecto Biotech, which is commercialising research from Lund and Edinburgh universities.
Oct 29, 2018Sitka absorbs $1.9m
Quark Venture and GF Securities have invested $1.9m in Sitka Biopharma, a spinout of University of British Columbia and Centre for Drug Research and Development.
Oct 29, 2018Galecto collects $90m in series C
Bristol Myers-Squibb, Merck Group and Novo all took part in a $90m series C round for Galecto Biotech that was co-led by Ysios Capital and OrbiMed.
Oct 29, 2018About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


